类风湿关节炎的患病率真的在上升吗？
[Is the prevalence of rheumatoid arthritis truly on the rise?].
作者信息
Albrecht Katinka, Callhoff Johanna, Strangfeld Anja
机构信息
Programmbereich Epidemiologie und Versorgungsforschung, Deutsches Rheuma-Forschungszentrum Berlin, Charitéplatz 1, 10117, Berlin, Deutschland.
Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Charité Universitätsmedizin Berlin, Berlin, Deutschland.
出版信息
Z Rheumatol. 2022 May;81(4):323-327. doi: 10.1007/s00393-022-01192-7. Epub 2022 Mar 31.
Abstract
A growing number of health insurance data analyses show an increase in the prevalence of rheumatoid arthritis (RA) in Germany. The studies refer to the claims diagnosis of RA, which is more frequent in recent years compared to earlier periods. Depending on the case definition, the numbers vary between 0.6% and 1.4% of the adult population. In this paper, the different studies are reviewed with regard to their data sources, the case definitions of RA and the frequency of the diagnosis. Due to the lack of clinical validation, the prevalence cannot be precisely determined from claims data.
摘要
越来越多的健康保险数据分析表明，德国类风湿性关节炎（RA）的患病率呈上升趋势。这些研究参考了RA的理赔诊断情况，与早期相比，近年来这种诊断更为频繁。根据病例定义，该数字在成年人口的0.6%至1.4%之间有所不同。本文对不同研究的数据来源、RA的病例定义以及诊断频率进行了综述。由于缺乏临床验证，无法从理赔数据中精确确定患病率。
相似文献
1
[Is the prevalence of rheumatoid arthritis truly on the rise?].类风湿关节炎的患病率真的在上升吗？
Z Rheumatol. 2022 May;81(4):323-327. doi: 10.1007/s00393-022-01192-7. Epub 2022 Mar 31.
2
[Prevalence of rheumatoid arthritis in Germany based on health insurance data : Regional differences and first results of the PROCLAIR study].[基于健康保险数据的德国类风湿性关节炎患病率：地区差异及PROCLAIR研究的初步结果]
Z Rheumatol. 2016 Oct;75(8):819-827. doi: 10.1007/s00393-016-0088-0.
3
[Prevalence of Rheumatoid Arthritis in Germany: Analysis of Longitudinal Data of Statutory Health Insurance].[德国类风湿关节炎患病率：法定医疗保险纵向数据分析]
Gesundheitswesen. 2021 May;83(5):367-373. doi: 10.1055/a-1192-4628. Epub 2020 Aug 28.
4
Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014.2004-2014 年美国医疗保健索赔数据库中成年人群类风湿关节炎的流行率。
Rheumatol Int. 2017 Sep;37(9):1551-1557. doi: 10.1007/s00296-017-3726-1. Epub 2017 Apr 28.
5
Prevalence of patients with rheumatoid arthritis and age-stratified trends in clinical characteristics and treatment, based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan.基于日本全国健康保险理赔和特定健康检查数据库的类风湿性关节炎患者患病率以及临床特征和治疗的年龄分层趋势。
Int J Rheum Dis. 2020 Dec;23(12):1676-1684. doi: 10.1111/1756-185X.13974. Epub 2020 Oct 5.
6
[Guideline-Orientated Prescription of Disease-Modifying Drugs in Patients with Rheumatoid Arthritis - an Analysis Based on Social Health Insurance Claims Data].[类风湿关节炎患者疾病改善药物的指南导向处方——基于社会医疗保险理赔数据的分析]
Dtsch Med Wochenschr. 2019 Jun;144(12):e70-e79. doi: 10.1055/a-0759-5202. Epub 2019 Jan 17.
7
The validity of the claims-based definition of rheumatoid arthritis evaluated in 64 hospitals in Japan.在日本64家医院对基于索赔的类风湿性关节炎定义的有效性进行了评估。
BMC Musculoskelet Disord. 2021 Apr 22;22(1):373. doi: 10.1186/s12891-021-04259-9.
8
Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study.德国类风湿关节炎、银屑病关节炎和银屑病患者的流行病学和治疗：一项真实世界证据研究。
Adv Ther. 2021 Jan;38(1):366-385. doi: 10.1007/s12325-020-01522-8. Epub 2020 Oct 30.
9
[Prevalence, comorbidity and interdisciplinary treatment of rheumatoid arthritis - Insurance data on outpatient and inpatient care in Baden-Württemberg].[类风湿关节炎的患病率、合并症及跨学科治疗——巴登-符腾堡州门诊和住院医疗的保险数据]
Z Rheumatol. 2018 Mar;77(2):113-126. doi: 10.1007/s00393-017-0381-6.
10
Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization.韩国类风湿关节炎的患病率和发病率更新及医疗保健和药物利用情况分析。
Rheumatol Int. 2018 Apr;38(4):649-656. doi: 10.1007/s00296-017-3925-9. Epub 2018 Jan 4.
引用本文的文献
1
[Rheuma in motion-A positioning of exercise and movement-therapy in chronic inflammatory rheumatic diseases].[动态风湿病——运动疗法在慢性炎症性风湿性疾病中的定位]
Z Rheumatol. 2025 Aug 13. doi: 10.1007/s00393-025-01693-1.
2
[T-cell large granular lymphocytic leukemia and Felty's syndrome in rheumatoid arthritis].[类风湿关节炎中的T细胞大颗粒淋巴细胞白血病和费尔蒂综合征]
Z Rheumatol. 2025 Feb;84(1):48-56. doi: 10.1007/s00393-024-01611-x. Epub 2025 Jan 24.
3
[Epidemiological data and medical care situation of patients with chronic inflammatory diseases in Germany : Real-world evidence on prevalence, disease combinations, care].德国慢性炎症性疾病患者的流行病学数据与医疗状况：关于患病率、疾病组合及护理的真实世界证据
Z Rheumatol. 2024 Sep;83(7):578-586. doi: 10.1007/s00393-023-01459-7. Epub 2023 Dec 9.
4
Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany.系统评价估计德国炎症性风湿病的患病率。
Z Rheumatol. 2024 Feb;83(Suppl 1):20-30. doi: 10.1007/s00393-022-01302-5. Epub 2023 Feb 7.
5
[Immune-mediated inflammatory diseases in Germany : A cross-sectional analysis of comorbidities and pharmacotherapy].[德国的免疫介导性炎症疾病：合并症与药物治疗的横断面分析]
Z Rheumatol. 2024 Apr;83(3):200-209. doi: 10.1007/s00393-022-01306-1. Epub 2023 Jan 4.
6
[Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany. German version].[德国炎症性风湿性疾病患病率的系统评价。德文版]
Z Rheumatol. 2023 Nov;82(9):727-738. doi: 10.1007/s00393-022-01305-2. Epub 2023 Jan 2.
本文引用的文献
1
All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015-2019.2015-2019 年，治疗中的系统性风湿病患者的全因死亡率与普通人群相比。
RMD Open. 2021 Nov;7(3). doi: 10.1136/rmdopen-2021-001694.
2
Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study.德国类风湿关节炎、银屑病关节炎和银屑病患者的流行病学和治疗：一项真实世界证据研究。
Adv Ther. 2021 Jan;38(1):366-385. doi: 10.1007/s12325-020-01522-8. Epub 2020 Oct 30.
3
[Prevalence of Rheumatoid Arthritis in Germany: Analysis of Longitudinal Data of Statutory Health Insurance].[德国类风湿关节炎患病率：法定医疗保险纵向数据分析]
Gesundheitswesen. 2021 May;83(5):367-373. doi: 10.1055/a-1192-4628. Epub 2020 Aug 28.
4
[Frequencies of musculoskeletal symptoms and disorders in the population-based German National Cohort (GNC)].[基于人群的德国国家队列（GNC）中肌肉骨骼症状和疾病的发生率]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Apr;63(4):415-425. doi: 10.1007/s00103-020-03110-1.
5
[The baseline assessment of the German National Cohort (NAKO Gesundheitsstudie): participation in the examination modules, quality assurance, and the use of secondary data].[德国国家队列研究（NAKO健康研究）的基线评估：参与检查模块、质量保证及二次数据的使用]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Mar;63(3):254-266. doi: 10.1007/s00103-020-03093-z.
6
[Which patients with rheumatoid arthritis do not receive DMARD treatment? Analysis of data from the German Collaborative Arthritis Centers].哪些类风湿关节炎患者未接受改善病情抗风湿药治疗？来自德国协作关节炎中心的数据分析
Z Rheumatol. 2020 Mar;79(2):153-159. doi: 10.1007/s00393-019-00712-2.
7
[Prevalence, comorbidity and interdisciplinary treatment of rheumatoid arthritis - Insurance data on outpatient and inpatient care in Baden-Württemberg].[类风湿关节炎的患病率、合并症及跨学科治疗——巴登-符腾堡州门诊和住院医疗的保险数据]
Z Rheumatol. 2018 Mar;77(2):113-126. doi: 10.1007/s00393-017-0381-6.
8
[Outpatient care and disease burden of rheumatoid arthritis : Results of a linkage of claims data and a survey of insured persons].[类风湿关节炎的门诊护理与疾病负担：索赔数据与被保险人调查的关联结果]
Z Rheumatol. 2018 Mar;77(2):102-112. doi: 10.1007/s00393-017-0294-4.
9
[How frequent are musculoskeletal diseases in Germany?].[德国肌肉骨骼疾病的发病率如何？]
Z Rheumatol. 2016 May;75(4):346-53. doi: 10.1007/s00393-016-0094-2.
10
[Prevalence of rheumatoid arthritis in Germany based on health insurance data : Regional differences and first results of the PROCLAIR study].[基于健康保险数据的德国类风湿性关节炎患病率：地区差异及PROCLAIR研究的初步结果]
Z Rheumatol. 2016 Oct;75(8):819-827. doi: 10.1007/s00393-016-0088-0.
Zotero 插件